Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Its defining physicochemical feature is resistance to hydrolysis at low pH, unusual for a peptide of this length and attributed to a proline-rich, conformationally constrained backbone carrying three consecutive prolines plus a fourth at position eight
Presented for research literature review only Holley EA et al
The synergy rationale is based on complementary mechanisms from individual component research (200+ BPC-157 studies, 170+ TB-500 studies)
BPC-157 has been shown to upregulate epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), fibroblast growth factor-2 (FGF-2), and nerve growth factor (NGF) expression in multiple rodent tissue models
Patients who should wait before starting BPC-157: those with active malignancy or a personal history of hormone-sensitive cancer, pregnant patients, and anyone who has not yet completed a basic anti-inflammatory protocol for an acute injury
BPC-157 enhances VEGFR2 activity and stimulates the Akt-eNOS pathway, driving nitric oxide production and new blood vessel formation
US$ 26.95
US$ 21.60
US$ 25.24
US$ 28.73
US$ 22.55
